We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Health Canada

News List

Health Canada accepts marketing application for Mithra’s hormone therapy Tibelia pharmaceufical-technology
October 12, 2017
Health Canada has accepted a marketing authorisation application for the Belgian pharmaceutical company Mithra’s complex therapeutic Tibelia, a tibolone-based product, to be used in hormone therapy (HT).
Sanofi Genzyme Announces Approval of Cerdelga by Health Canada americanpharmaceuticalreview
May 02, 2017
Sanofi Genzyme, a division of Sanofi-Aventis Canada Inc., announced Health Canada has approved Cerdelga (eliglustat capsules) for the treatment of adult patients with Gaucher Disease Type 1.

Previous page 1 2 3 Next page